DOCSLIB.ORG

70596—Cool Command® Senior Horse Feed (Texturized)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
70596—Cool Command® Senior Horse Feed (Texturized) MULTI-FORM SENIOR TEXTURIZED Equine Supplement GUARANTEED ANALYSIS Crude Protein, min 14.0 % Phosphorus, min 0.5 % Lysine, min 0.79 % Copper, min 45 PPM Methionine, min 0.2 % Selenium, min 0.3 PPM Threonine, min 0.5 % Zinc, min 80 PPM Crude Fat, min 8.0 % Vitamin A, min 4,000 IU/LB Crude Fiber, max 20.0 % Vitamin D, min 400 IU/LB Acid Detergent Fiber, max 22.0 % Vitamin E, min 100 IU/LB Neutral Detergent Fiber, max 32.0 % Biotin, min 0.6 MG/LB Starch, max 13.0 % *Glucosamine HCL, min 500 MG/LB Sugars, max 7.2 % *Condroitin Sulfate, min 350 MG/LB Calcium, min 0.9 % *Methylsulfonylmethane, min 500 MG/LB Calcium, max 1.4 % *Not recognized as an essential dietary nutrient INGREDIENTS Grain products, roughage products, plant protein products, molasses products, forage products, processed grain by- products, vegetable oil, calcium carbonate, calcium phosphate, salt, L-lysine, glucosamine hydrochloride, methylsulfonylmethane, zinc proteinate, potassium chloride, vitamin E supplement, sodium carboxymethylcellulose, manganese proteinate, ascorbic acid, chondroitin sulfate, sodium sulfate, potassium sulfite, propylene glycol, copper proteinate, hydrolyzed yeast, natural flavor, artificial flavor, iron proteinate, propionic acid (a preservative), sorbic acid (a preservative), acetic acid (a preservative), benzoic acid (a preservative), selenium yeast, ferrous sulfate, calcium pantothenate, niacin supplement, mineral oil, zinc oxide, thiamine mononitrate, manganese sulfate, cobalt proteinate, riboflavin supplement, menadione nicotinamide bisulfite (source of vitamin K activity), vitamin A supplement, pyridoxine hydrochloride, copper sulfate, manganous oxide, vitamin B-12 supplement, folic acid, vitamin D-3 supplement, ethylenediamine dihydroiodide, biotin, menadione sodium bisulfite complex (source of vitamin K activity). WARNING: This product, which contains added copper, should not be fed to sheep or related species that have a low tolerance to copper. This product has been formulated specifically for horses and is not intended for other species. Caution: Follow label directions. Feeding this feed containing added selenium at levels higher than recommended is not permitted. FEEDING DIRECTIONS: Feed Cool Command Multi-Form Senior Texturized to horses that cannot eat hays/pastures due to poor teeth, age, or other health related problems. Cool Command Multi-Form Senior Texturized is also an ideal ration for horses affected with a dust sensitive condition, such as heaves. Feeding with forage: Offer the average adult horse 7-10 pounds of Cool Command Multi-Form Senior Texturized along with the equivalent amount of forage. Feeding as a sole ration: Feed the average adult horse 17-20 pounds of Cool Command Multi-Form Senior Texturized per head per day (1.7 to 2% body weight). Offer hay to help relieve boredom. Adjust amounts depending upon body condition. A constant supply of clean, fresh water is necessary for optimum results. Hubbard does not use "Restricted-use Proteins" in their products and is in compliance with FDA and state requirements regarding the use, handling and storage of "Restricted-use Protein" products. HUBBARD FEEDS 111 West Cherry Street Suite 500 Mankato, MN 56001 Net Weight 40 lb (18.14 kg) or bulk invoice. 70596 REV 12/20 .
Load more

Recommended publications
  • An Abstract of the Thesis Of
    AN ABSTRACT OF THE THESIS OF Larry Stanford Merrifield for the M.S. in Food Science (Name) (Degree) (Major) Date thesis is presented June 26, 1964 Titie FACTORS AFFECTING THE ANTIMICROBIAL ACTIVITY OF VITAMIN K 5 Abstract approved (M^jor Tp&Sfesso/) Vitamin K, 4-amino-2-methyl- 1-naphthol hydrochloride, a 5 water soluble analog of vitamin K has been shown to possess an anti- microbial activity toward many bacteria, molds, and yeast. Much of the work reported in the literature is on its use as a food preserva- tive, and it was the purpose of this study to investigate some of the factors which might affect the antimicrobial activity of vitamin K in order to add insight into its more effective use as a food preserva- tive. Pure cultures of Escherichia coli, Bacillus subtilis, Proteus vulgaris, Staphlococcus aureus, and Pseudomonas fluorescens were utilized. The effect of the method of application of vitamin K on Escherichia coli; the effect of purity of vitamin K against Escherichia coli; the bactericidal concentrations required for Escherichia coli, Bacillus subtilis, Proteus vulgaris, Staphlococcus aureus, and Pseudomonas fluorescens; the effect of an absence of oxygen; the effect of contact time with Escherichia coli; the effect of initial count/ml of Escherichia coli; and the synergistic action in combination with propylene glycol were studied. The results demonstrated that air oxidation of vitamin K was 5 necessary to obtain maximum inhibitory activity against Escherichia coli. The use of white, crystalline vitamin K synthesized in the laboratory, as compared to partially oxidized commercial prepara- tions, gave better results against Escherichia coli.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,149,560 B2 Askari Et Al
    USOO9149560B2 (12) United States Patent (10) Patent No.: US 9,149,560 B2 Askari et al. (45) Date of Patent: Oct. 6, 2015 (54) SOLID POLYGLYCOL-BASED 6,149,931 A 11/2000 Schwartz et al. BOCOMPATIBLE PRE-FORMULATION 6,153,211 A 11/2000 Hubbell et al. 6,180,687 B1 1/2001 Hammer et al. 6,207,772 B1 3/2001 Hatsuda et al. (71) Applicant: Medicus Biosciences LLC, San Jose, 6,312,725 B1 1 1/2001 Wallace et al. CA (US) 6,458,889 B1 10/2002 Trollsas et al. 6,475,508 B1 1 1/2002 Schwartz et al. (72) Inventors: Syed H. Askari, San Jose, CA (US); 6,547,714 B1 4/2003 Dailey 6,566,406 B1 5/2003 Pathak et al. Yeon S. Choi, Emeryville, CA (US); 6,605,294 B2 8/2003 Sawhney Paul Yu Jen Wan, Norco, CA (US) 6,624,245 B2 9, 2003 Wallace et al. 6,632.457 B1 10/2003 Sawhney (73) Assignee: Medicus Biosciences LLC, San Jose, 6,703,037 B1 3/2004 Hubbell et al. CA (US) 6,703,378 B1 3/2004 Kunzler et al. 6,818,018 B1 1 1/2004 Sawhney 7,009,343 B2 3/2006 Lim et al. (*) Notice: Subject to any disclaimer, the term of this 7,255,874 B1 8, 2007 Bobo et al. patent is extended or adjusted under 35 7,332,566 B2 2/2008 Pathak et al. U.S.C. 154(b) by 0 days. 7,553,810 B2 6/2009 Gong et al.
    [Show full text]
  • Stability of Vitamins in Pelleting
    Stability of vitamins in pelleting BY N.E. WARD, PHD, MSC REVIEWED AND EDITED BY CHARLES STARK, ADAM FAHRENHOLZ, AND CASSANDRA JONES with formulation changes from the same supplier. elleting of animal feeds has been practiced for P For these reasons, historical data must be closely decades. During the pelleting process, an increased scrutinized. processing temperature is associated with the production of more tonnes of feed per hour with Vitamin stability characteristics improved pellet durability. If conditions are harsh Inherent differences exist in the stability of enough, however, reduced starch (Brown, 1996) unformulated vitamins (i.e., non-commercial forms; and protein (Batterham, et al., 1993) utilization can Baker, 1995). Thus, while heat may be especially occur. destructive to vitamin A, it has little consequence on niacin (Table 16-1). Vitamins for use in feeds In addition, the moisture, heat, friction and shear of and foods are formulated to counter anticipated pelleting can compromise the integrity of added stresses, and formulations are intended to act as a vitamins (Jones, 1986; Gadient, 1986) and enzymes buffer between the vitamin and the destructive (Nunes, 1993; Eeckhout, 1999). Taken that the component. various feed additives are inherently vulnerable to heat and moisture, this is not a minor concern. Along with the unique chemical structure and Thus, it’s important to understand the conditions characteristics of each vitamin, the anticipated that might decrease the efficacy of enzymes and stress dictates the type of stabilization or vitamins in a processed feed. formulation needed. For example, vitamin A exists with four double bonds and one hydroxyl group (Adams, 1978).
    [Show full text]
  • (12) STANDARD PATENT (11) Application No. AU 2010224615 B2 (19) AUSTRALIAN PATENT OFFICE
    (12) STANDARD PATENT (11) Application No. AU 2010224615 B2 (19) AUSTRALIAN PATENT OFFICE (54) Title Dietary supplement (51) International Patent Classification(s) A23K 1/175 (2006.01) A23K1/18 (2006.01) (21) Application No: 2010224615 (22) Date of Filing: 2010.02.12 (87) WIPONo: WO10/106351 (30) Priority Data (31) Number (32) Date (33) Country 0904584.0 2009.03.17 GB (43) Publication Date: 2010.09.23 (44) Accepted Journal Date: 2014.05.08 (71) Applicant(s) Calinnova Ltd (72) Inventor(s) Green, Malcolm Geoffrey (74) Agent / Attorney Davies Collison Cave, Level 14 255 Elizabeth Street, Sydney, NSW, 2000 (56) Related Art ARNBJERG, J. "Hypokalcaemi hos hest. En kasuistik med diskussion (Hypocalcemia in the horse. A case report)" Nord Vet Med, 1980, Volume 32, Issue 5 Pages 207-211 US 2003/0077254 A1 (RAMAEKERS) 24 April 2003 FR 2625415 A1 (UNICOR UNION COOP AGRICOLES) 07 July 1989 HUDSON, NPH et al., "Primary Hypothyroidism in Two Horses" Australian Veterinary Journal, 1999, Volume 77, Number 8, Pages 504-508 GRUBB, T.L. et al., "Hemodynamic Effects of Calcium Gluconate Administered to Conscious Horses" Journal of Veterinary Internal Medicine, 1996, Volume 10 Number 6 Pages 401-404 US 2008/0014304 A1 (ZELLER et al.) 17 January 2008 ANONYMOUS, "Finish Line Thia-cal" [Retrieved on 23 April 2013] Retrieved from internet <URL: http://www.doversaddlery.eom/finish-line-thia-cal-gallon/p/X1-22069/> published on 30 December 2005 ANONYMOUS, "Humavyte" [Retrieved on 23 April 2013] Retrieved from internet <URL: http://web.archive.org/web/20080719131829/http://www.ranvet.com.au/
    [Show full text]
  • Mega-Dose Vitamin C As Therapy for Human Cancer?
    possible alternative explanation for the positive outcome.... LETTER Finally, these case reports omit the number of patients who received high-dose intravenous vitamin C therapy with no effect. Because these cases were collected over many years Mega-dose vitamin C as therapy for from several institutions, this number may be quite large and human cancer? the overall response rate quite low’’ (5). Frei and Lawson (1) also refer to the ‘‘remarkable tolerance for high-dose i.v. vitamin C’’ in a phase I trial in selected cancer patients (12) Frei and Lawson (1) paint a rosy picture of the potential of but fail to mention the conclusion of this trial: ‘‘No patient vitamin C as therapy for human cancer. The authors are lo- experienced an objective anticancer response . .’’ (12). cated at the Linus Pauling Institute and therefore are in a It is possible that ‘‘the promise of ascorbic acid in the special position to revitalize the interest in vitamin C pro- treatment of advanced cancer may lie in combination with moted by the articles of Cameron and Pauling in PNAS 30 cytotoxic agents’’ (12). As long as this has not been tested, we years ago; however, the evidence that vitamin C could help should try to avoid a new hype of vitamin C as cancer treat- human cancer patients is still thin. ment by pointing out, especially in PNAS, the limitations of 1. Chen et al. (2) find that megadose i.p. vitamin C results in an the available data. Ϸ2-fold growth decrease of a human (Ovcar 5), a mouse Piet Borst1 (PanO2), and a rat (9L) tumor xenografted into immuno- compromised mice.
    [Show full text]
  • US5116406.Pdf
    |||||||||||||| US005 16406A United States Patent (19) 11) Patent Number: 5,116,406 Hyeon (45) Date of Patent: May 26, 1992 (54) PLANT GROWTH REGULATING 4.799,950 l/1989 Suzuki et al. ........................... 71/89 COMPOSITION FOREIGN PATENT DOCUMENTS 75 Inventor: Suong B. Hyeon, Urawa, Japan 61-215305(A) 3/1985 Japan. (73) Assignee: Mitsubishi Gas Chemical Company, 60-72802(A) 4/1985 Japan. Inc., Tokyo, Japan 61-212502(A) 9/1986 Japan. 62-190102(A) 8/1987 Japan . (21) Appl. No.: 540,062 2059412A 8/1980 United Kingdom . 22 Filed: Jun. 19, 1990 Primary Examiner-Glennon H. Hollrah Assistant Examiner-John D. Pak (30) Foreign Application Priority Data Attorney, Agent, or Firm-Armstrong, Nikaido, Jun. 20, 1989 (JP) Japan .................................. - 155629 Marmelstein, Kubovcik & Murray 5) Int. C. ...................... A01N 41/04; AOlN 33/12 (57) ABSTRACT 52 U.S. Cl. .......................................... 71/103; 71/77; Disclosed is a plant growth regulating composition, 71/92; 71/121; 71/123 which comprises containing at least one of choline salts 58) Field of Search ..................... 71/121, 123, 77,92, and compounds having vitamin K3 activity as active 71/103 ingredients and a plant growth regulating composition, (56) References Cited and comprises containing at least one of choline salt, U.S. PATENT DOCUMENTS compounds having vitamin K3 activity and compounds 4.309.205 l/1982 Kessler .................................. 7 1/21 having vitamin B activity as active ingredients. 4.337.077 1/1982 Rutherford ... ... 71/9 4,764.20 8/1988 lino et al. ................................ 7/77 3 Claims, No Drawings 5,116,406 1 2 menadiol dibutyrate. The above salts are preferably PLANT GROWTH REGULATING COMPOSITION sodium salts and potassium salts.
    [Show full text]
  • Which Supplements Can I Recommend to My Osteoarthritis Patients?
    Rheumatology 2018;57:iv75iv87 RHEUMATOLOGY doi:10.1093/rheumatology/key005 Advance Access publication 1 March 2018 Which supplements can I recommend to my osteoarthritis patients? Downloaded from https://academic.oup.com/rheumatology/article-abstract/57/suppl_4/iv75/4916021 by Stellenbosch University user on 27 May 2019 Xiaoqian Liu1,2, Jillian Eyles1,2,3, Andrew J. McLachlan4 and Ali Mobasheri5,6 Abstract OA is a chronic and disabling joint disease with limited evidence-based pharmacological treatment op- tions available that improve outcomes for patients safely. Faced with few effective pharmacological treat- ments, the use has grown of dietary supplements and complementary medicines for symptomatic relief among people living with OA. The aim of this review is to provide a summary of existing evidence and recommendations supporting the use of supplements for OA. Systematic reviews and randomized con- trolled trials investigating oral supplements for treating OA were identified. Limited research evidence supports recommendations for the oral use of Boswellia serrata extract and Pycnogenol, curcumin and methylsulfonylmethane in people with OA despite the poor quality of the available studies. Few studies adequately reported possible adverse effects related to supplementation, although the products were generally recognized as safe. Further high quality trials are needed to improve the strength of evidence to support this recommendation and better guide optimal treatment of people living with OA. Key words: osteoarthritis, supplements, self-management, treatment, recommendations, complementary medicines Rheumatology key messages . Limited evidence supports the use Boswellia serrata extract, Pycnogenol, curcumin and methylsulfonylmethane for OA. Available evidence does not support some widely used supplements such as glucosamine and chondroitin for OA.
    [Show full text]
  • MSM) Levels in Human Plasma Ling Lin1,2*, Dejian Ma1, Richard J
    ition & F tr oo OPEN ACCESS Freely available online u d N f S o c l i e a n n c r e u s o J ISSN: 2155-9600 Journal of Nutrition & Food Sciences Research Article Development and Application of an LC-MS/MS Method for Determining Methylsulfonylmethane (MSM) levels in Human Plasma Ling Lin1,2*, Dejian Ma1, Richard J. Bloomer3, Matthew Butawan3 , Webb A. Smith4,5, Charles R. Yates6 1Department of Pharmaceutical Sciences, University of Tennessee College of Pharmacy, Memphis, TN, USA; 2Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China; 3Center for Nutraceutical and Dietary Supplement Research, School of Health Studies, University of Memphis, Memphis, TN, USA Savar; 4Department of Pediatrics, University of Tennessee College of Medicine, Memphis, TN, USA; 5Children’s Foundation Research Institute, LeBonheur Children’s Hospital, Memphis, TN, USA; 6The National Center for Natural Products Research, Oxford, MS, USA ABSTRACT Methylsulfonylmethane (MSM) isan organosulfur phytochemical widely used as a dietary supplement carrying structure/function claims that includethe promotion of joint health. Untargeted metabolomics studies using nuclear magnetic resonance (NMR) have identified MSM in plasma and urine. However, MS-based methodology is more suitable for pharmacokinetic studies designed to explore MSM’s concentration-effect relationship for purposes of establishing dosing guidelines. To address this deficiency, an LC-MS/MS method using MSM, deuterated MSM (MSM-d6, internal standard), and liquid-liquid extraction was developed and validated in accordance with international guidelines. The method proved well-suited for determining MSM levels in human plasma following chronic oral administration (1, 2, or 3 grams daily) for four weeks.
    [Show full text]
  • Dietary Supplements for Osteoarthritis Philip J
    Dietary Supplements for Osteoarthritis PHILIP J. GREGORY, PharmD; MORGAN SPERRY, PharmD; and AmY FRIEdmAN WILSON, PharmD Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska A large number of dietary supplements are promoted to patients with osteoarthritis and as many as one third of those patients have used a supplement to treat their condition. Glucosamine-containing supplements are among the most commonly used products for osteo- arthritis. Although the evidence is not entirely consistent, most research suggests that glucos- amine sulfate can improve symptoms of pain related to osteoarthritis, as well as slow disease progression in patients with osteoarthritis of the knee. Chondroitin sulfate also appears to reduce osteoarthritis symptoms and is often combined with glucosamine, but there is no reliable evi- dence that the combination is more effective than either agent alone. S-adenosylmethionine may reduce pain but high costs and product quality issues limit its use. Several other supplements are promoted for treating osteoarthritis, such as methylsulfonylmethane, Harpagophytum pro- cumbens (devil’s claw), Curcuma longa (turmeric), and Zingiber officinale (ginger), but there is insufficient reliable evidence regarding long-term safety or effectiveness. Am( Fam Physician. 2008;77(2):177-184. Copyright © 2008 American Academy of Family Physicians.) ietary supplements, commonly glycosaminoglycans, which are found in referred to as natural medicines, synovial fluid, ligaments, and other joint herbal medicines, or alternative structures. Exogenous glucosamine is derived medicines, account for nearly from marine exoskeletons or produced syn- D $20 billion in U.S. sales annually.1 These thetically. Exogenous glucosamine may have products have a unique regulatory status that anti-inflammatory effects and is thought to allows them to be marketed with little or no stimulate metabolism of chondrocytes.4 credible scientific research.
    [Show full text]
  • Dietary Supplements Compendium Volume 1
    2015 Dietary Supplements Compendium DSC Volume 1 General Notices and Requirements USP–NF General Chapters USP–NF Dietary Supplement Monographs USP–NF Excipient Monographs FCC General Provisions FCC Monographs FCC Identity Standards FCC Appendices Reagents, Indicators, and Solutions Reference Tables DSC217M_DSCVol1_Title_2015-01_V3.indd 1 2/2/15 12:18 PM 2 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Dietary Supplements Compendium of a monograph on any dietary supplement in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner. Concerning Use of the USP Dietary Supplements Compendium Attention is called to the fact that USP Dietary Supplements Compendium text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Legal Department of the United States Pharmacopeial Convention. Copyright © 2015 The United States Pharmacopeial Convention ISBN: 978-1-936424-41-2 12601 Twinbrook Parkway, Rockville, MD 20852 All rights reserved. DSC Contents iii Contents USP Dietary Supplements Compendium Volume 1 Volume 2 Members . v. Preface . v Mission and Preface . 1 Dietary Supplements Admission Evaluations . 1. General Notices and Requirements . 9 USP Dietary Supplement Verification Program . .205 USP–NF General Chapters . 25 Dietary Supplements Regulatory USP–NF Dietary Supplement Monographs .
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0225053 A1 Dushenkov Et Al
    US 20120225053A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0225053 A1 Dushenkov et al. (43) Pub. Date: Sep. 6, 2012 (54) COMPOSITIONS AND METHODS FOR THE A6IP 9/02 (2006.01) PREVENTION AND TREATMENT OF A6IP 7/06 (2006.01) CONDITIONS ASSOCATED WITH A63L/7008 (2006.01) NFLAMATION A638/48 (2006.01) A6IR 36/287 (2006.01) (76) Inventors: Slavik Dushenkov, Fort Lee, NJ A 6LX 3L/75 (2006.01) (US); Patricia Lucas-Schnarre, A638/39 (2006.01) Metuchen, NJ (US); Julie Beth A6II 35/60 (2006.01) Hirsch, Branchburg, NJ (US); A636/906 (2006.01) David Evans, Belle Mead, NY A6IR 36/16 (2006.01) (US); Kitty Evans, legal A6IR 36/258 (2006.01) representative, Merritt Island, FL A636/87 (2006.01) (US) A636/76 (2006.01) A636/736 (2006.01) (21) Appl. No.: 11/920,973 A636/8 (2006.01) A6IP 29/00 (2006.01) (22) PCT Filed: May 24, 2006 (52) U.S. Cl. ........ 424/94.65: 514/456; 514/62; 424/771; (86). PCT No.: PCT/USO6/2O542 514/54: 514/17.2: 424/523; 424/756; 424/752: 424/728; 424/766; 424/769; 424/735; 424/760 S371 (c)(1), (2), (4) Date: May 2, 2012 (57) ABSTRACT Related U.S. Application Data The present invention provides methods for preventing, treat ing, managing and/or ameliorating a condition associated (60) Provisional application No. 60/684,487, filed on May with inflammation (e.g., an inflammatory disorder) or a 24, 2005. symptom thereof, the methods comprising administering to a subject in need thereof an effective amount of a theaflavin Publication Classification composition and an effective amount of one or more therapies (51) Int.
    [Show full text]
  • Glucosamine + Chondroitin + MSM Supports Joint Health*
    Jarrow® QUICKReference Guide FORMULAS healthy living through science & education Glucosamine + Chondroitin + MSM Supports Joint Health* Glucosamine + Chondroitin + MSM Combination provides efficacious quantities of Glucosamine Sulfate, Chondroitin Sulfate, and MSM combined with Vitamin C and Manganese for joint health.* PRODUCT CATEGORY Joint Who Can Benefit From this Product? Supplement Facts Serving Size 4 Capsules Anyone with suboptimal joint function who wants to promote joint Amount Per Serving % DV mobility, flexibility, and comfort may find this product beneficial.* Vitamin C 60 mg 100% Manganese 1 mg 50% Glucosamine Sulfate • 2 KCI 2000 mg * Yielding: Glucosamine Sulfate 1500 mg What Distinguishes this Product? Potassium Chloride 500 mg Chondroitin Sulfate (low molecular weight) 1200 mg * • Sodium-Free Glucosamine Sulfate (from 1333 mg Chondroitin Sulfate Sodium) Methylsulfonylmethane 300 mg * • 1.5 g Glucosamine Sulfate and 1.2 g Chondroitin Sulfate Per Serving (providing 102 mg of organic sulfur) - Quantities consistent with clinical research * Daily Value not established. • Also Contains Vitamin C and Manganese Other Ingredients - Needed in the synthesis of collagen and cartilage Magnesium stearate (vegetable source), cellulose, and silicon dioxide. Capsule consists of gelatin. Contains: Shellfish (shrimp). No wheat, no gluten, no soybeans, no dairy, no egg, How Does Each Active Ingredient Function in no fish, no peanuts/tree nuts. this Product? Suggested Usage Glucosamine Stimulates proteoglycan production found in joint Take 4 capsules per day, or as directed by your qualified health care consultant. Sulfate cartilage* Chondroitin Attracts shock-absorbing fluid to proteoglycans* Note MSM A sulfur source for inclusion in joints* Do NOT use if allergic to shellfish. If you have a medical condition, are pregnant, lactating, or trying Vitamin C Needed for synthesis of collagen* to conceive, are under the age of 18, or are taking medications, consult your health care practitioner Manganese Needed for synthesis of cartilage* before using this product.
    [Show full text]